Outset Medical begins selling TabloCart again after FDA nod
Outset Medical (Nasdaq: OM) announced today that the FDA granted 510(k) clearance for its TabloCart with Prefiltration.
Source: massdevice.com
Stay updated with breaking news from Outset Tablo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Outset Medical (Nasdaq: OM) announced today that the FDA granted 510(k) clearance for its TabloCart with Prefiltration.